(Q84612087)

English

Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol

scientific article published on 29 July 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668473%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668473%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

myeloid leukemia

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

childhood acute myeloid leukemia

1 reference

based on heuristic

inferred from title

Jacques Van Dongen

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668473%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

V H J van der Velden

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668473%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

A van der Sluijs-Geling

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668473%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

B E S Gibson

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668473%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

J G te Marvelde

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668473%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

P G Hoogeveen

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668473%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

W C J Hop

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668473%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

K Wheatley

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668473%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

M B Bierings

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668473%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

G J Schuurhuis

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668473%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

S S N de Graaf

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668473%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

E R van Wering

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668473%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

29 July 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668473%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668473%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668473%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1599-1606

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668473%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668473%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

https://scigraph.springernature.com/pub.10.1038/leu.2010.153

0 references

Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical relevance of minimal residual disease detection in adult acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: reference patterns for age-related changes and disease-induced shifts

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease in acute myeloid leukemia in children--standardization and evaluation of immunophenotyping in the AML-BFM-98 study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoring.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Stability of leukemia-associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: comparison with cytomorphologic, cytogenetic, and molecular genetic findings

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantification of CBFB-MYH11 fusion gene levels in paired peripheral blood and bone marrow samples by real-time PCR.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survival.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

A probabilistic approach for the evaluation of minimal residual disease by multiparameter flow cytometry in leukemic B-cell chronic lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84612087&oldid=2035075305"